Markets:

Overview

News

Currencies

International

Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ:COCH)

0.6864 +0.0070 (+1.03%)

Streaming Delayed Price Updated: 10:11 AM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Envoy Medical, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

September 22, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Monday's pre-market session: top gainers and losers ↗

September 22, 2025

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

September 22, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

September 19, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Topics Intellectual Property

Top movers in Friday's pre-market session ↗

September 12, 2025

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 12, 2025

Via Benzinga

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

September 10, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - September 10, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Topics Intellectual Property

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

September 09, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - September 9, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Topics Intellectual Property

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

September 08, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - September 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Topics Intellectual Property

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

September 03, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - September 3, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 26, 2025

Via Benzinga

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

August 26, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - August 26, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Topics Intellectual Property Retirement

EXCLUSIVE: Envoy Medical Retires $32 Million Debt, Glen Taylor Steps Down From Board After Two Decades ↗

August 26, 2025

Envoy Medical settled $32 million in loans for $100K and announced Glen Taylor's retirement after 20 years, citing confidence in its clinical trial progress.

Via Benzinga

Topics Retirement

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 20, 2025

Via Benzinga

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

August 20, 2025

Patents issued in the U.S., Australia, and Hong Kong advance Envoy Medical's innovation pipeline and protect next-generation cochlear implant solutions...

Via Newsfile

Topics Intellectual Property

Envoy Medical Reports on Second Quarter 2025 Results

July 31, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - July 31, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing...

Via Newsfile

Topics Intellectual Property

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

July 08, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - July 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Topics Intellectual Property

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

July 01, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - July 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Topics Intellectual Property

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

June 26, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - June 26, 2025) - Envoy Medical, Inc. (NASDAQ: COCH), a revolutionary hearing health company...

Via Newsfile

Life Sciences Investor Forum: Now Available for Online Viewing

June 13, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

June 11, 2025

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Investor Forum Agenda Announced for June 11th-12th

June 10, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

June 10, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - June 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing...

Via Newsfile

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

May 13, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - May 13, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing...

Via Newsfile

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 09, 2025

Via Benzinga

Envoy Medical Reports on First Quarter 2025 Results

May 01, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - May 1, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing...

Via Newsfile

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

March 31, 2025

Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device,...

Via Newsfile

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

March 17, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - March 17, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing...

Via Newsfile

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

March 12, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - March 12, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing...

Via Newsfile

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.